Addition of an endothelin receptor antagonist to modified Belzer’s perfusion preservation solution mitigates the adverse effect of preretrieval warm ischemic injury on posttransplant glomerular filtration rate
- 30 August 2001
- journal article
- Published by Elsevier BV in Transplantation Proceedings
- Vol. 33 (6), 2975-2976
- https://doi.org/10.1016/s0041-1345(01)02277-1
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- INCREASED URINARY EXCRETION OF ENDOTHELIN DURING HYPOTHERMIC PERFUSION PRESERVATION IN KIDNEYS SUBJECTED TO PRERETRIEVAL WARM ISCHEMIC INJURYTransplantation, 2000
- IDENTIFICATION OF KIDNEYS SUBJECTED TO PRERETRIEVAL WARM ISCHEMIC INJURY BY SIMULTANEOUS MONITORING OF GLOMERULAR FILTRATION AND PERFUSATE FLOW DURING HYPOTHERMIC PERFUSION PRESERVATIONTransplantation, 1999
- CONTRIBUTION OF ENDOTHELIN-1 TO MICROCIRCULATORY IMPAIRMENT IN TOTAL HEPATIC ISCHEMIA AND REPERFUSION INJURYTransplantation, 1999
- Improvement of Postischemic Acute Renal Failure with the Novel Orally Active Endothelin-A Receptor Antagonist LU 135252 in the RatJournal of Cardiovascular Pharmacology, 1998
- Transplantation of Kidneys from Donors Whose Hearts Have Stopped BeatingNew England Journal of Medicine, 1998
- THE USE OF A NOVEL MONITORING APPARATUS AND MODIFIED BELZER HYDROXYETHYL STARCH PERFUSATE FOR ANALYSIS OF GLOMERULAR FILTRATION DURING HYPOTHERMIC PERFUSION PRESERVATION1Transplantation, 1996
- Comparison of a Novel ETA Receptor Antagonist and Phosphoramidon in Renal IschemiaPharmacology, 1995
- Protective effect of a selective endothelin receptor antagonist, BQ-123, in ischemic acute renal failure in ratsEuropean Journal of Pharmacology, 1992